Differences in cytochrome P450 3A4 (CYP3A4) expression alone do not explain inter-individual variability in CYP3A-mediated hepatic testosterone 6β hydroxylase (TST6βOH) activity

被引:0
|
作者
Barter, Z. E. [1 ]
Crewe, K. H. [1 ]
Harlow, J. R. [1 ]
Lei, Y. [1 ]
Tucker, G. T. [1 ]
Rostami-Hodjegan, A. [1 ]
机构
[1] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
129
引用
收藏
页码:98 / 98
页数:1
相关论文
共 50 条
  • [21] Prosubstrates of CYP3A4, the major human hepatic cytochrome P450 - Transformation into substrates by other P450 isoforms
    Stresser, DM
    Kupfer, D
    BIOCHEMICAL PHARMACOLOGY, 1998, 55 (11) : 1861 - 1871
  • [22] Potential role of cytochrome P450 3A4 (CYP3A4) in the PCB104-mediated barrier dysfunction of human microvascular endothelial cells
    Lee, Y
    Eum, S
    Hennig, B
    Toborek, M
    FASEB JOURNAL, 2004, 18 (05): : A991 - A991
  • [23] Modelling cytochrome P450 inhibition using large datasets of in vitro assays for CYP 2D6 and CYP 3A4
    Mao, B
    Gozalbes, R
    Barbosa, F
    Migeon, J
    Rogalski, S
    Kamm, K
    Wong, E
    Costales, C
    Shi, W
    Froloff, N
    Horvath, D
    Wu, C
    DRUG METABOLISM REVIEWS, 2004, 36 : 343 - 343
  • [24] MEDI 202-Structural dynamics of the cooperative binding of organic molecules in the human Cytochrome P450 3A4 (CYP3A4)
    Fishelovitch, Dan
    Hazan, Carina
    Shaik, Sason
    Wolfson, Haim
    Nussinov, Ruth
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [25] Cytochrome P450 3A4 (CYP3A4) protein quantification using capillary western blot technology and total protein normalization
    Collins, Joseph M.
    Wang, Danxin
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2021, 112
  • [26] P-glycoprotein (P-gp) plays a significant role in enhancing intestinal metabolism by cytochrome P450 3A4 (CYP3A4)
    Cummins, CL
    Benet, LZ
    FASEB JOURNAL, 2001, 15 (04): : A548 - A548
  • [27] Influence of Various Polymorphic Variants of Cytochrome P450 Oxidoreductase (POR) on Drug Metabolic Activity of CYP3A4 and CYP2B6
    Chen, Xuan
    Pan, Li Qiang
    Naranmandura, Hua
    Zeng, Su
    Chen, Shu Qing
    PLOS ONE, 2012, 7 (06):
  • [28] Molecular modeling and 3D-QSAR analysis of the inhibition of cytochrome P450 3A4 (CYP3A4) by dillapiol and its derivatives.
    Wang, K
    Budzinski, JW
    Foster, BC
    Durst, T
    Arnason, JT
    Compadre, CM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U47 - U48
  • [29] Simultaneous assessment of cytochrome P450 activity in cultured human hepatocytes for compound-mediated induction of CYP3A4, CYP2B6, and CYP1A2
    Rhodes, Susan P.
    Otten, Jennifer N.
    Hingorani, Gary P.
    Hartley, Dylan P.
    Franklin, Ronald B.
    JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2011, 63 (03) : 223 - 226
  • [30] Comparison of CYP3A4 and CYP3A5: The Effects of Cytochrome b5 and NADPH-cytochrome P450 Reductase on Testosterone Hydroxylation Activities
    Lee, Su-Jun
    Gldstein, Joyce A.
    DRUG METABOLISM AND PHARMACOKINETICS, 2012, 27 (06) : 663 - 667